Doxycycline Sclerotherapy of Mandibular Aneurysmal Bone Cysts: A Brief Clinical Study

J Craniofac Surg. 2025 Jan-Feb;36(1):e31-e33. doi: 10.1097/SCS.0000000000010697. Epub 2024 Sep 23.

Abstract

Aneurysmal bone cysts (ABCs) are benign bone tumors typically affecting children. Mandibular ABCs can be difficult to treat surgically, given their sensitive anatomic location and functional and cosmetic impacts. This report presents 3 pediatric patients with mandibular ABCs successfully treated with image-guided percutaneous doxycycline sclerotherapy. The first 2 patients presented with pain and swelling, whereas the third was diagnosed incidentally. Sclerotherapy was the sole treatment for cases 1 and 2, whereas case 3 had sclerotherapy after recurrence following prior surgeries. In all 3 patients, clinical symptoms resolved, and stable bone healing was documented on long-term follow-up. There were no functional or cosmetic complications. Doxycycline sclerotherapy is a safe and viable treatment for primary and recurrent mandibular ABCs.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / therapeutic use
  • Bone Cysts, Aneurysmal* / diagnostic imaging
  • Bone Cysts, Aneurysmal* / therapy
  • Child
  • Doxycycline* / therapeutic use
  • Female
  • Humans
  • Male
  • Mandibular Diseases* / diagnostic imaging
  • Mandibular Diseases* / therapy
  • Sclerosing Solutions / therapeutic use
  • Sclerotherapy* / methods

Substances

  • Doxycycline
  • Sclerosing Solutions
  • Anti-Bacterial Agents